Asymchem Launches European Manufacturing Site In The U.K

Asymchem Laboratories Co., Ltd. has launched its new European development and pilot manufacturing facility at Discovery Park in Sandwich, Kent, U.K. The site, previously used by Pfizer for small molecule production, now has 70 staff members working in R&D and the API pilot plant, including many former Pfizer employees. The company plans to increase its workforce by the end of the year as the pilot plant scales up operations.

Asymchem aims to enhance its site by incorporating advanced technologies for smarter, greener, and more cost-effective manufacturing processes. By 2025, the facility will be equipped with state-of-the-art machinery for producing peptides and oligonucleotides, as well as sustainable solutions for continuous flow processes and biocatalysis.

Dr. Hao Hong, Chairman, Founder, and CEO of Asymchem, stated,“This is an exciting milestone for Asymchem to meet growing demand for pharma services and supply. We are continuing a long legacy of manufacturing excellence at Discovery Park, with the location in Kent being ideal for reaching our target markets in Europe.”